Published in Genetics on June 01, 2002
Genome-wide analysis of tRNA charging and activation of the eIF2 kinase Gcn2p. J Biol Chem (2009) 1.64
Quantitative genome-wide analysis of yeast deletion strain sensitivities to oxidative and chemical stress. Comp Funct Genomics (2004) 1.11
Pressure-induced differential regulation of the two tryptophan permeases Tat1 and Tat2 by ubiquitin ligase Rsp5 and its binding proteins, Bul1 and Bul2. Mol Cell Biol (2003) 1.08
Membrane stress is coupled to a rapid translational control of gene expression in chlorpromazine-treated cells. Curr Genet (2007) 0.90
Inhibition of translation initiation by volatile anesthetics involves nutrient-sensitive GCN-independent and -dependent processes in yeast. Mol Biol Cell (2005) 0.89
Functional profiling discovers the dieldrin organochlorinated pesticide affects leucine availability in yeast. Toxicol Sci (2013) 0.80
Antimicrobial effects of liquid anesthetic isoflurane on Candida albicans. J Transl Med (2006) 0.78
Tetracaine, a local anesthetic, preferentially induces translational inhibition with processing body formation rather than phosphorylation of eIF2α in yeast. Curr Genet (2014) 0.77
Pressure-induced endocytic degradation of the Saccharomyces cerevisiae low-affinity tryptophan permease Tat1 is mediated by Rsp5 ubiquitin ligase and functionally redundant PPxY motif proteins. Eukaryot Cell (2013) 0.76
New yeast-Escherichia coli shuttle vectors constructed with in vitro mutagenized yeast genes lacking six-base pair restriction sites. Gene (1988) 42.65
High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr Genet (1989) 31.80
Sterile host yeasts (SHY): a eukaryotic system of biological containment for recombinant DNA experiments. Gene (1979) 19.39
A new efficient gene disruption cassette for repeated use in budding yeast. Nucleic Acids Res (1996) 11.05
On the relevance of "clinically relevant concentrations" of inhaled anesthetics in in vitro experiments. Anesthesiology (1999) 3.20
NPl1, an essential yeast gene involved in induced degradation of Gap1 and Fur4 permeases, encodes the Rsp5 ubiquitin-protein ligase. Mol Microbiol (1995) 3.19
Cdc48p interacts with Ufd3p, a WD repeat protein required for ubiquitin-mediated proteolysis in Saccharomyces cerevisiae. EMBO J (1996) 3.09
Starvation induces vacuolar targeting and degradation of the tryptophan permease in yeast. J Cell Biol (1999) 2.80
Components of a ubiquitin ligase complex specify polyubiquitination and intracellular trafficking of the general amino acid permease. J Cell Biol (2001) 2.65
Ubiquitin-dependent internalization and down-regulation of plasma membrane proteins. FASEB J (1997) 2.45
Molecular interactions between inhaled anesthetics and proteins. Pharmacol Rev (1997) 2.31
Relevant concentrations of inhaled anesthetics for in vitro studies of anesthetic mechanisms. Anesthesiology (2001) 1.87
Ssy1p and Ptr3p are plasma membrane components of a yeast system that senses extracellular amino acids. Mol Cell Biol (1999) 1.83
Classification of all putative permeases and other membrane plurispanners of the major facilitator superfamily encoded by the complete genome of Saccharomyces cerevisiae. FEMS Microbiol Rev (1997) 1.77
Bul1, a new protein that binds to the Rsp5 ubiquitin ligase in Saccharomyces cerevisiae. Mol Cell Biol (1996) 1.73
Substrate specificity and gene expression of the amino-acid permeases in Saccharomyces cerevisiae. Curr Genet (1999) 1.63
Yeast multidrug resistance: the PDR network. J Bioenerg Biomembr (1995) 1.61
Inhibition of dopamine transport in rat brain synaptosomes by volatile anesthetics. Anesthesiology (1993) 1.47
Two FK506 resistance-conferring genes in Saccharomyces cerevisiae, TAT1 and TAT2, encode amino acid permeases mediating tyrosine and tryptophan uptake. Mol Cell Biol (1994) 1.46
Mutations affecting RNA polymerase I-stimulated exchange and rDNA recombination in yeast. Genetics (1991) 1.43
BAP2, a gene encoding a permease for branched-chain amino acids in Saccharomyces cerevisiae. Biochim Biophys Acta (1995) 1.41
The effect of two genes on anesthetic response in the nematode Caenorhabditis elegans. Anesthesiology (1988) 1.25
Brain metabolism of branched-chain amino acids. Glia (1997) 1.25
The immunosuppressant FK506 inhibits amino acid import in Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.19
Suppressors of ssy1 and ptr3 null mutations define novel amino acid sensor-independent genes in Saccharomyces cerevisiae. Genetics (2001) 1.17
Amino acids induce expression of BAP2, a branched-chain amino acid permease gene in Saccharomyces cerevisiae. J Bacteriol (1996) 1.12
Cloning and sequencing of the Saccharomyces cerevisiae gene LYP1 coding for a lysine-specific permease. Yeast (1993) 1.11
Molecular genetic analysis of volatile-anesthetic action. Mol Cell Biol (1996) 0.96
Ubiquitin metabolism affects cellular response to volatile anesthetics in yeast. Mol Cell Biol (1999) 0.95
Genetic differences affecting the potency of stereoisomers of halothane. Proc Natl Acad Sci U S A (1994) 0.93
Interrelationships of leucine and glutamate metabolism in cultured astrocytes. J Neurochem (1994) 0.88
The N-terminal domain of the yeast permease Bap2p plays a role in its degradation. Biochem Biophys Res Commun (2001) 0.86
The impact of drugs used in anaesthesia on bacteria. Eur J Anaesthesiol (1999) 0.82
Sodium-coupled neutral amino acid cotransporter inhibited by the volatile anesthetic, halothane, in megakaryocytes. Jpn J Physiol (1995) 0.81
TAT1 encodes a low-affinity histidine transporter in Saccharomyces cerevisiae. Biochem Biophys Res Commun (1998) 0.81
Volatile anesthetic additivity and specificity in Saccharomyces cerevisiae: implications for yeast as a model system to study mechanisms of anestheitc action. Anesthesiology (1998) 0.80
What are "relevant" concentrations? Anesthesiology (2001) 0.76
The liver X receptor ligand T0901317 decreases amyloid beta production in vitro and in a mouse model of Alzheimer's disease. J Biol Chem (2004) 1.75
In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3. Ann Neurol (2002) 1.74
An HSV vector system for selection of ligand-gated ion channel modulators. Nat Methods (2007) 1.57
Peripherally delivered glutamic acid decarboxylase gene therapy for spinal cord injury pain. Mol Ther (2004) 1.56
Gene transfer of glutamic acid decarboxylase reduces neuropathic pain. Ann Neurol (2005) 1.47
Gene therapy for pain: results of a phase I clinical trial. Ann Neurol (2011) 1.31
Protein kinase C epsilon contributes to basal and sensitizing responses of TRPV1 to capsaicin in rat dorsal root ganglion neurons. Eur J Neurosci (2008) 1.12
HSV-mediated gene transfer of the glial cell-derived neurotrophic factor provides an antiallodynic effect on neuropathic pain. Mol Ther (2003) 1.07
Effects of transgene-mediated endomorphin-2 in inflammatory pain. Eur J Pain (2008) 1.06
Protective effect of herpes simplex virus-mediated neurotrophin gene transfer in cisplatin neuropathy. Brain (2004) 1.04
Long-term neuroprotection achieved with latency-associated promoter-driven herpes simplex virus gene transfer to the peripheral nervous system. Mol Ther (2005) 0.96
Treatment of rat gliosarcoma brain tumors by HSV-based multigene therapy combined with radiosurgery. Mol Ther (2003) 0.93
Hyperactive Himar1 transposase mediates transposition in cell culture and enhances gene expression in vivo. Hum Gene Ther (2006) 0.91
Prolonged biologically active transgene expression driven by HSV LAP2 in brain in vivo. Mol Ther (2004) 0.91
Inhibition of translation initiation by volatile anesthetics involves nutrient-sensitive GCN-independent and -dependent processes in yeast. Mol Biol Cell (2005) 0.89
Gene transfer of human manganese superoxide dismutase protects small intestinal villi from radiation injury. J Gastrointest Surg (2003) 0.88
HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice. Mol Ther (2006) 0.88
Inhibition of mammalian translation initiation by volatile anesthetics. Am J Physiol Endocrinol Metab (2006) 0.85
Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnol Prog (2002) 0.84
Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification. J Virol (2004) 0.83
Bcl-2 and GDNF delivered by HSV-mediated gene transfer after spinal root avulsion provide a synergistic effect. J Neurotrauma (2002) 0.82
Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnol Bioeng (2002) 0.82
Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception. Hum Gene Ther (2013) 0.81
Delivery using herpes simplex virus: an overview. Methods Mol Biol (2004) 0.81
Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors. Biotechnol Bioeng (2002) 0.80
Gene Therapy for Pain: A Perspective. Pain Manag (2011) 0.80
Construction of replication-defective herpes simplex virus vectors. Curr Protoc Hum Genet (2002) 0.80
Interdisciplinary graduate education: a case study. Cell (2011) 0.78
Enhanced functional recovery after proximal nerve root injury by vector-mediated gene transfer. Exp Neurol (2003) 0.78
Generation of replication-competent and -defective HSV vectors. Cold Spring Harb Protoc (2011) 0.77
RRD1, a component of the TORC1 signalling pathway, affects anaesthetic response in Saccharomyces cerevisiae. Yeast (2009) 0.77
Suicide gene therapy of human hepatoma and its peritonitis carcinomatosis by a vector of replicative-deficient herpes simplex virus. Biochem Biophys Res Commun (2002) 0.76
Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase. Cancer Gene Ther (2005) 0.76
Gene transfer to glial tumors using herpes simplex virus. Methods Mol Biol (2004) 0.75
Delivery of herpes simplex virus-based vectors to the nervous system. Methods Mol Biol (2004) 0.75